InspireMD, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
NSPR$0.78+9.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(U.S. dollars in thousands, except share and per share data)
| 3 Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| REVENUES | $3,398 | $1,529 |
| COST OF REVENUES | 2,711 | 1,237 |
| GROSS PROFIT | 687 | 292 |
| OPERATING EXPENSES: | ||
| Research and development | 4,763 | 4,059 |
| Selling and marketing | 5,180 | 2,750 |
| General and administrative | 4,722 | 4,943 |
| Total operating expenses | 14,665 | 11,752 |
| LOSS FROM OPERATIONS | (13,978) | (11,460) |
| FINANCIAL INCOME, net | 289 | 294 |
| NET LOSS | $(13,689) | $(11,166) |
| NET LOSS PER SHARE - basic and diluted | (0.16) | (0.22) |
| WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - basic and diluted | 83,801,839 | 49,993,509 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.